Definitive Healthcare Corp. appointed Jason Krantz as new CEO

Item 5.02 
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 


Separation of Chief Executive Officer 

On January 16, 2024, the Company announced that Robert Musslewhite has stepped down as the Company's Chief Executive Officer and as a member of the Company's Board of Directors, effective January 16, 2024 (the "Separation Date"). 

Mr. Musslewhite's departure constitutes a termination of employment without "cause" for purposes of any employment, equity compensation or benefit agreement, plan or arrangement of the Company and its subsidiaries to which Mr. Musslewhite is a party or otherwise participates; provided, however, that pursuant to a separation agreement and release of claims agreement dated January 12, 2024 (the "Separation Agreement"), the Company has agreed to credit Mr. Musslewhite with an additional three months of accelerated vesting with respect to his outstanding time-based equity awards (for a total of 15 months) and to reimburse him up to $15,000 for legal fees incurred by him in connection with the Separation Agreement. 

A copy of the Separation Agreement is attached as Exhibit 10.1 to this Current Report on Form 8-K. 

Appointment of Interim Chief Executive Officer 

On January 12, 2024, the Company's Board of Directors appointed Jason Krantz, the Company's founder and Executive Chairman, as Interim Chief Executive Officer, effective January 16, 2024. 

Mr. Krantz, age 50, has served as Executive Chairman of the Board of Directors of the Company since August 2022, having previously served as Chief Executive Officer and director since founding the Company in February 2011. Prior to founding Definitive Healthcare, Mr. Krantz founded and served as CEO of Infinata, a SaaS based provider of intelligence to the pharmaceutical industry under the brand BioPharm Insight, from 1999 to 2007 until the company was sold to Pearson Media Group. In addition, Mr. Krantz has co-founded and helped build several intelligence and analytics companies including Energy Acuity, a privately held provider of intelligence on the alternative energy market, and Xtelligent Media, a privately held integrated marketing company focused on the healthcare industry. Mr. Krantz previously served on the board of directors of RainKing Solutions, a private company, from 2015 until 2017. Mr. Krantz is currently on the board of directors of FINTRX and MDCalc, each private companies. Mr. Krantz holds a B.S. in Finance and Computer Science from Boston College and an M.B.A. from Harvard Business School. 

There are no related person transactions within the meaning of Item 404(a) of Regulation S-K promulgated by the Securities and Exchange Commission between Mr. Krantz and the Company other than those described under the heading "Certain Relationships and Related Party Transactions" in the Company's Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission April 6, 2023.